Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Nu Skin Enterprises Inc is a household & personal products business based in the US. Nu Skin Enterprises shares (NUS) are listed on the NYSE and all prices are listed in US Dollars. Nu Skin Enterprises employs 5,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $50.56 |
|---|---|
| 52-week range | $39.08 - $62.00 |
| 50-day moving average | $48.02 |
| 200-day moving average | $50.75 |
| Wall St. target price | $53.60 |
| PE ratio | 14.9619 |
| Dividend yield | $1.515 (2.8%) |
| Earnings per share (TTM) | $4.43 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $50.56 from 2022-01-21
| 1 week (2022-01-14) | -6.82% |
|---|---|
| 1 month (2021-12-23) | 2.14% |
| 3 months (2021-10-22) | 23.11% |
| 6 months (2021-07-23) | -4.68% |
| 1 year (2021-01-22) | -12.56% |
|---|---|
| 2 years (2020-01-24) | 38.86% |
| 3 years (2019-01-24) | 63.32 |
| 5 years (2017-01-24) | 51.71 |
Valuing Nu Skin Enterprises stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Nu Skin Enterprises's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Nu Skin Enterprises's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Nu Skin Enterprises shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Nu Skin Enterprises's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.35. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Nu Skin Enterprises's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Nu Skin Enterprises's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $378.9 million.
The EBITDA is a measure of a Nu Skin Enterprises's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.8 billion |
|---|---|
| Operating margin TTM | 10.91% |
| Gross profit TTM | $1.9 billion |
| Return on assets TTM | 9.97% |
| Return on equity TTM | 2607.38% |
| Profit margin | 8.3% |
| Book value | $18.69 |
| Market capitalisation | $2.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 34.31% of net profits
Recently Nu Skin Enterprises has paid out, on average, around 34.31% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.8% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Nu Skin Enterprises shareholders could enjoy a 2.8% return on their shares, in the form of dividend payments. In Nu Skin Enterprises's case, that would currently equate to about $1.515 per share.
While Nu Skin Enterprises's payout ratio might seem fairly standard, it's worth remembering that Nu Skin Enterprises may be investing much of the rest of its net profits in future growth.
Nu Skin Enterprises's most recent dividend payout was on 7 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 23 November 2021 (the "ex-dividend date").
Over the last 12 months, Nu Skin Enterprises's shares have ranged in value from as little as $39.0782 up to $61.9953. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Nu Skin Enterprises's is 1.2397. This would suggest that Nu Skin Enterprises's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.